Surface markers of lymphoblasts in acute lymphoblastic leukaemia by Rajajee, S et al.
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58 children with acute lymphoblastic leukaemia (ALL) were studied for the effect of initial clinical and laboratory
features and surface markers of lymphoblasts on the prognosis. 18.9% of them had T cell leukaemia while 3.4% had
B-cell leukaemia. Six pre-treatment features were related to T-cell ALL, i.e. - age over 6 years, boys, presence of
mediastinal enlargement, haemoglobin over 8g/dl, markedly elevated leucocyte count and CNS involvement. 90% of
T-Cell ALL survived for less than 6 months. Both the cases of B-cell leukaemia died within 8 weeks. Identification of
T and B cell leukaemia warrants more aggressive treatment for these patients to achieve remission and survive longer.
The presenting clinical and laboratory features of
children with acute lymphoblastic leukaemia (ALL)
are recognised as key determinants for prognosis in
childhood ALL. Certain clinical features are associated
with shorter duration of remissions.Lymphoblast
surface makers are important criteria in the prognosis
of the disease1.
58 children with ALL admitted into the Institute
of Child health, Madras during the period May 1980
to August 1984 were studied for the effect of initial
clinical and laboratory features as well as surface markers
of lymphoblasts on the prognosis of these children.
The subjects were 58 children with ALL admitted
during the period May 1980 to August 1984.
Blast cells from initial bone marrow aspirates were
obtained. The diagnosis of ALL was made when blast
cells showed no evidence of auer rods and no myeloid
or monocytic differentiation. In patients where the
peripheral blood contained more than 90% blasts,
peripheral blood was taken for lymphoblast surface
markers. Central nervous system (CNS) leukaemia was
determined by the presence of blast cells in CSF.
T-rosettes were enumerated
et al2 and B (EAC) rosettes
et al3.
by the method of Jondal
by the method of Bianco
Resu l t s
Of the 58 children studied, 11 (18.9%) were
identified as having E+ ALL, since they had lympho-
blasts that formed rosettes with sheep erythrocytes at
37°C. The range of E+ lymphoblasts was 72 to 95%
with a mean of 82.5%.
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As indicated in Table 1, majority of children with
T-cell leukaemia were boys over 6 years. The mean
duration of illness before hospitalisation was 3-6 weeks.
6 of them (54.5%) had mediastinal enlargement;
54.5% had an initial haemoglobin value of above
8 gm/dl while 5 (55.4%) had a leucocyte count of
above 100 x 109/l. 90% had thrombocytopenia. 6 of
the children (54.5%) had CNS leukaemia of whom
3 had bilateral facial palsy. 3 children had testicular
relapse.
In spite of intensive chaemotherapy with vincris-
tine, adriamycin and steroids for remission induction,
preventive CNS therapy with 1800 rads of cranial
irradiation plus intrathecal methotrexate followed by
maintenance therapy, survival was less than 6 months
in all except 1 child who lived for nearly 10 months. 
Table 2 indicates the differences in the clinical
signs in T-cell and Null cell leuakemias. The group with
null cell leukaemias was mostly below 6 years with
equal distribution in boys and girls. Haemoglobin was
below 8 gm/dl in 73%.    Total leucocyte count was below
100 x 109/l in 80%. Mediastinal enlargement was
present in only 4%, while CNS leukaemia occured in
2%. Two of these children are in continuous remission
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or 3 years, 4 for 2 years and 4 for nearly 1 year. Many
(60%) did not continue treatment or died soon after
admission.
Table 2 :
No. of Patients
Features
T (11) Null (45)
Age (Years)
Sex
Six pre-treatment features were related to E+
lymphoblasts (age, sex, mediastinal enlargement, haemo-
globin, leucocyte count and CNS involvement).
2 children (3.4%) had B-cell leukaemias. There
was involvement of vertebrae in one of them. Morpho-
logically the lymphoblasts had cytoplasmic vacuoles.
Both died within 6 to 8 weeks of therapy.
Discussion
The incidence of T-cell leukaemia has been vari-
ously reported as 15 to 20%4, 20 to 25%5, 24%1 of
ALL in children. In the present series, it was 18.9%
of the ALL. The clinical features of patients with T-cell
leukaemia are distinctive.
Six initial clinical characteristics were related to
the presence of E+ lymphoblasts (1) age over 6 years
(2) boys, (3) haemoglobinover 8 gm/dl (4)
markedly elevated leucocyte count (5) mediastinal
enlargement and (6) CNS involvement. These features
were related to a poor clinical outcome despite intensive
chemotherapy. Sen and Borella6 initially related the
presence of mediastinal enlargement, age over 5 years,
boys and elevated leukocyte count with E+ blasts.
Dow L. W. et al 1 have made similar observations,
but in addition to the above features they also related
lymph nodes greater than 2 cms. in any diameter,
lymphadenopathy outside the cervical region and liver
enlargement greater than 5 cms. to the presence of E+
lymphoblasts. These features were not found to be
relavant to T-cell leukaemia in the present series.
Tsukimoto et al7 found that the presence of a
T-cell marker on leukaemic blasts was not related to
age in a series of 37 patients with ALL. Brout et al8
found no-correlation between E+ lymphoblasts and
either age or sex in their 100 patients but 30% of those
patients were over 20 years of age.
Leukaemia presentation of E+ ALL is a later deve-
lopment of malignant extramedullay diseases while
E-ALL presumably arises within the marrow and
presents initially as leukaemia. The higher haemoglobin
levels among T-cell ALL as compared to null cell ALL,
with low platelet count and extensive marrowinfilt-
ration prevailing in both groups, implies that haemato-
poises is suppressed later in the course of T-cell ALL.
As the platelets are short lived, they show an early
decrease in concentration while the longer lived erythro-
cytes remain close to normal concentrations for some
time. With continuing suppression, the number of
erythrocytes also drops1.
The identification of the type of lymphoblast can
lead to more effective treatment. In cases of T-and B
cell leukaemias, in addition to the normal remission
induction with vincristine and steroids, one or two more
drugs have to be included to achieve remission and for
longer survival.
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